The Global Biological Imaging market is anticipated to grow from $13816 million in 2016 to $27584 million by 2025, at a CAGR of 7.91% between 2016 and 2025. Biologic imaging reagents play a fundamental role in today’s medical, pharmaceutical and biotechnological industries. Optical imaging reagents allow life sciences researchers and drug developers to visualize and detect biological processes at the molecular level and to perform key genomics, 

GLOBAL BIOLOGICAL IMAGING REAGENT MARKET FORECAST 2017-2025

Biological Imaging Reagent Market by (Class, Technology, End User, Application, End-use, Modality) & Geography

Request free sample

The Global Biological Imaging market is anticipated to grow from $13816 million in 2016 to $27584 million by 2025, at a CAGR of 7.91% between 2016 and 2025. Biologic imaging reagents play a fundamental role in today’s medical, pharmaceutical and biotechnological industries. Optical imaging reagents allow life sciences researchers and drug developers to visualize and detect biological processes at the molecular level and to perform key genomics, proteomics, and cellular analysis assays.

Biological Imaging Reagent Market

To know more about this report, request a free sample copy

The Biological Imaging market is primarily driven by the following factors:

  • Increase in the demand for imaging technologies
  • Increased accessibility to cutting edge laser eye medication
  • Development of newer, targeted imaging agents and expansion of imaging technologies

The important driver increasing growth in the global Biological Imaging Market is increasing demand for imaging technologies. Advances in technologies that are used in biologic imaging reagents are also moving forward at a rapid pace. These technologies include nanotechnology, biologic targeting, microfluidics, supramolecular chemistry and protein engineering. Rapid developments across a number of technology fields promise to change the biological imaging industry by enabling novel imaging reagents and unique market opportunities.

The applications and technologies of biological imaging market are used extensively for various purposes. Contrast imaging can be used to study many organs and structures in your body. Optical imaging is a technique for noninvasive visualization of the inside of the body, as is done with x-rays. Nuclear medicine is a division of medicinal imaging that uses small quantities of radioactive substantials to determine and diagnose the sternness or extravagance a diversity, of diseases. Small chemicals molecules are small molecular masses that include second messengers, monosaccharides, lipids, other natural products, and metabolites. Probes include organic dyes, which may also be conjugated with various biochemicals that include proteins, antibodies or oligonucleotides. A radioactive label, or radioactive tracer, is a chemical composite in which single or many atoms have been substituted by a radioisotope. By feature of its radioactive deterioration, it can be used to discover the machinery of chemical responses by outlining the track that the radioisotope trails from reactants to products. Chelation allows metals to be conveyed to and fro from susceptible target locates and facilitates or hinders their carcinogenic potential. The distinctive capability of micro bubbles to retort to ultrasound sorts those valuable mediators for molecular imaging, contrast ultrasound imaging, and targeted gene delivery and drug. Nanoparticle is a tiny element with at best one dimension fewer than 100 nm.

Technological and scientific advances increasing the cost of reagents and the need for less toxic/hazardous reagents are the major factors hindering the biological imaging market. Technological and scientific advances along with the increasing understanding of the basic mechanisms of disease are raising the development of latest drugs and cures for patients. But at the same time, complexities and cost of biopharmaceutical research have also increased, which is hampering the research and development process. A trend affecting the growth of specific market segments within imaging reagents is driving the need for less toxic/hazardous reagents.

The Global Biological Imaging market segments include class, technologies, end users, end use, modality, and applications.

The class is segmented into:

  • Contrast reagents
  • Optical reagents
  • Nuclear reagents

Technologies are segmented into:

  • Small chemicals
  • Probes
  • Radiotracers
  • Chelating molecules
  • Micro bubbles
  • Fluorescent proteins
  • Nanoparticles

End Users are segmented into:

  • Diagnostics
  • Research and development

End-Use is segmented into:

  • In-vivo
  • In-vitro

Modality is segmented into:

  • Optical
  • X-ray/CT
  • Nuclear
  • MRI
  • Ultrasound

Applications are segmented into:

  • Contrast imaging
  • Optical imaging
  • Radioactive imaging

This report covers the present market conditions and the growth prospects of the global Biological Imaging market for 2017-2025 and considered the revenue generated through the sales of Biological Imaging for Class, Technologies, End Users, End Use, Modality and Applications to calculate the market size by considering 2016 as the base year.

Geographically, the Global Biological Imaging market has been segmented on the basis of four major regions, which include:

  • North America – U.S. & Canada
  • Asia-Pacific – China, India, Japan, Rest of APAC
  • Europe – UK, France, Germany, Rest of Europe
  • Rest of World- Latin America, Middle East and North Africa, Rest of Africa

The Biological Imaging market in North America is expected to hold the largest share by 2025. The U.S. and Canada are the major regions which help to drive the market of Biological Imaging Reagents in North America. The U.S. held the largest market share with a total of 73% in 2016. The growing pharmaceutical industry, surging government funding in life science-based research, and rising demand for GMO crops are pushing the market of Biological Imaging Reagents in the U.S. On the other hand, Rest of World is anticipated to be the fastest-growing region for the Biological Imaging market. The increasing healthcare investment and rising market of biotechnology-based industries are the major factors helping to increase the market for bio-imaging reagents in the forecast period 2017-2025. Latin America, Middle East, and North Africa are some of the other major regions of the world which help to fuel the market for bio-imaging reagents, globally in the forecast period.

The Biological Imaging Market is segmented based on Class, which is sub-divided into contrast reagents, optical reagents, nuclear reagent; on the basis of End User which is sub-divided into diagnostics, research, and development; on the basis of End-Use which is sub-divided into in-vivo and in-vitro; and on the basis of Modality which is sub-divided into Optical, X-ray/CT, Nuclear, MRI and Ultrasound. Contrast reagents are divided into two categories. The first one is paramagnetic compounds, including lanthanides like gadolinium, and the second class consists of superparamagnetic nanoparticles (SPMNPs) such as iron oxides. Optical reagents include products used in imaging applications ex: 3D Slicer. Nuclear reagents include imaging radiopharmaceuticals. Diagnostic imaging refers to a variety of non-invasive methods for identifying and monitoring diseases or injuries via the generation of images. The research and development market segment includes drug discovery and development as well as government, academic and institutional research. In vivo denotes to research performed inside a living organism. In vitro refers to the technique of performing a given procedure in a controlled environment outside of a living organism. Optical Imaging is an emerging technology with great potential for improving disease prevention, diagnosis, and treatment in the medical office, at the bedside, or in the operating room. X-rays are a form of electromagnetic radiation. Nuclear medicine is a branch of medical imaging that uses radiopharmaceuticals to examine the function and structure of organs and tissues.

The major market players of the Global Biological Imaging market are:

  • BAYER HEALTHCARE PHARMACEUTICALS
  • BRACCO SPA
  • GE HEALTHCARE
  • LANTHEUS MEDICAL IMAGING INC
  • PERKINELMER, INC.

Company Profiles covers analysis of important players.

Bayer HealthCare Pharmaceuticals (Bayer Pharma or ‘the company’), formerly known as Bayer Schering Pharma, is a pharmaceuticals business arm of Bayer. It is a global research-based company engaged in the development, manufacture, and marketing of specialty-focused medicines, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology, and ophthalmology. Bayer Pharma was created through the merger of Bayer and Schering in 2006. It operates through its subsidiaries in more than 100 countries spread across Europe, the Americas, Asia Pacific, Africa and the Middle East. PerkinElmer (PerkinElmer or ‘the company’) offers products, services, and solutions focused on improving the health and safety of people and the environment. The company has manufacturing and assembly plants, research laboratories, administrative offices and other facilities located in 16 states in the US and 31 foreign countries.

Key Findings of the Global Biological Imaging market:

  • North America is the market leader
  • High market growth rate for nuclear imaging reagents by class
  • SPECT and PET imaging reagent is a rapidly growing segment of the pharmaceutical industry
  • Research and development is the fastest growing end-user segment
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • NORTH AMERICA IS THE MARKET LEADER
      • HIGH MARKET GROWTH RATE FOR NUCLEAR IMAGING REAGENTS BY CLASS
      • SPECT AND PET IMAGING REAGENT IS A RAPIDLY GROWING SEGMENT FOR THE PHARMACEUTICAL INDUSTRY
      • RESEARCH AND DEVELOPMENT IS THE FASTEST GROWING END-USER SEGMENT
  1. MARKET DETERMINANTS
    • DRIVERS
      • INCREASE IN THE DEMAND FOR IMAGING TECHNOLOGIES
      • INCREASED ACCESSIBILITY TO CUTTING EDGE LASER EYE MEDICATION
      • DEVELOPMENT OF NEWER, TARGETED IMAGING AGENTS AND EXPANSION OF IMAGING TECHNOLOGIES
    • RESTRAINTS
      • TECHNOLOGICAL AND SCIENTIFIC ADVANCES INCREASES THE COST OF REAGENTS
      • NEED FOR LESS TOXIC/HAZARDOUS REAGENTS
    • OPPORTUNITIES
      • RESEARCH IN ENVIRONMENTAL BIOTECHNOLOGY
      • DEVELOPMENT OF PIVOTAL INNOVATIONS
    • CHALLENGES
      • DIFFERENCES IN REGULATIONS
  1. MARKET SEGMENTATION
    • BY CLASS
      • CONTRAST REAGENTS
      • OPTICAL REAGENTS
      • NUCLEAR REAGENTS
    • BY TECHNOLOGY
      • SMALL CHEMICALS
      • PROBES
      • RADIOTRACERS
      • CHELATING MOLECULES
      • MICRO BUBBLES
      • FLUORESCENT PROTEINS
      • NANOPARTICLES
    • BY END USER
      • DIAGNOSTICS
      • RESEARCH AND DEVELOPMENT
    • BY APPLICATION
      • CONTRAST IMAGING
      • OPTICAL IMAGING
        • IN-VITRO
          • PROTEOMICS
          • GENOMICS
          • CELL BIOLOGY
        • IN-VIVO
      • RADIOACTIVE IMAGING
    • BY END-USE
      • IN-VIVO
      • IN-VITRO
    • BY MODALITY
      • OPTICAL
      • X-RAY/CT
      • NUCLEAR
        • SPECT
        • PET
      • MRI
      • ULTRASOUND
  1. KEY ANALYTICAL
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
      • BARGAINING POWER OF BUYER
      • BARGAINING POWER OF SUPPLIER
      • INTENSITY OF COMPETITIVE RIVALRY
    • PARAMETRIC ANALYSIS
      • BIOTECHNOLOGY FIRMS ACROSS COUNTRIES
      • GLOBAL PHARMACEUTICAL RESEARCH & DEVELOPMENT EXPENDITURE
    • KEY BUYING CRITERIA
      • SUSTAINABILITY
      • QUALITY OF PRODUCT
      • COST
      • AVAILABILITY
  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • UNITED STATES
      • CANADA
    • EUROPE
      • UNITED KINGDOM
      • FRANCE
      • GERMANY
      • REST OF EUROPE
    • ASIA PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • REST OF ASIA PACIFIC
    • REST OF THE WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND NORTH AFRICA
      • REST OF AFRICA
  1. COMPANY PROFILES
    • BAYER HEALTHCARE
    • BECKMAN-COULTER
    • BRACCO
    • EVIDENT TECHNOLOGIES
    • GE HEALTHCARE
    • JUBILANT ORGANOSYS
    • LANTHEUS MEDICAL IMAGING
    • LIFE TECHNOLOGIES
    • PERKINELMER
    • SCHERING AG
    • SIEMENS MEDICAL

 

LIST OF TABLES

TABLE 1        GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET, BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE 2       GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET, BY CLASS 2017-2025 ($ MILLION)

TABLE 3       GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY 2017-2025 ($ MILLION)

TABLE 4       GLOBAL MICROBUBBLES MARKET 2017-2025 ($ MILLION)

TABLE 5       GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET, BY END USER 2017-2025 ($ MILLION)

TABLE 6       GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET, BY APPLICATION 2017-2025 ($ MILLION)

TABLE 7       GLOBAL OPTICAL IMAGING MARKET 2017-2025 ($ MILLION)

TABLE 8       GLOBAL INVITRO OPTICAL IMAGING MARKET 2017-2025 ($ MILLION)

TABLE 9       GLOBAL PROTEOMICS MARKET 2017-2025 ($ MILLION)

TABLE 10     GLOBAL GENOMICS MARKET 2017-2025 ($ MILLION)

TABLE 11     GLOBAL CELL BIOLOGY MARKET 2017-2025 ($ MILLION)

TABLE 12     GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET, BY END USE 2017-2025 ($ MILLION)

TABLE 13     GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET, BY MODALITY 2017-2025 ($ MILLION)

TABLE 14     GLOBAL X-RAY/CT TYPE MARKET 2017-2025 ($ MILLION)

TABLE 15     GLOBAL X-RAY/CT INDICATION MARKET 2017-2025 ($ MILLION)

TABLE 16     GLOBAL NUCLEAR ISOTOPE MARKET 2017-2025 ($ MILLION)

TABLE 17     GLOBAL NUCLEAR INDICATION MARKET 2017-2025 ($ MILLION)

TABLE 18     GLOBAL NUCLEAR TECHNOLOGY MARKET 2017-2025 ($ MILLION)

TABLE 19     GLOBAL SPECT ISOTOPE MARKET 2017-2025 ($ MILLION)

TABLE 20     GLOBAL SPECT INDICATION MARKET 2017-2025 ($ MILLION)

TABLE 21     GLOBAL SPECT TECHNOLOGY MARKET 2017-2025 ($ MILLION)

TABLE 22     GLOBAL PET ISOTOPE MARKET 2017-2025 ($ MILLION)

TABLE 23     GLOBAL PET INDICATION MARKET 2017-2025 ($ MILLION)

TABLE 24     GLOBAL PET TECHNOLOGY MARKET 2017-2025 ($ MILLION)

TABLE 25     GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE 26     NORTH AMERICA BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)

TABLE 27     EUROPE BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)

TABLE 28     ASIA PACIFIC BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)

TABLE 29     REST OF THE WORLD BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)

LIST OF FIGURES

FIGURE # 1  NUMBER OF CANCER CASES AROUND THE WORLD (IN MILLION)

FIGURE # 2  INCIDENCE OF PEOPLE WITH HIV

FIGURE # 3  GLOBAL GERIATRIC POPULATION (65+) 2015 & 2020 (MILLION)

FIGURE # 4  YOUNG CHILDREN AND OLDER PEOPLE AS A PERCENTAGE OF GLOBAL POPULATION 1950-2050

FIGURE # 5  TOTAL HEALTH EXPENDITURE PER CAPITA IN US DOLLARS

FIGURE # 6  NUMBER OF HOSPITALS (2015)

FIGURE # 7  GLOBAL INSTRUMENT MARKET 2017-2025 ($MILLION)

FIGURE # 8  GLOBAL REAGENTS & CONSUMABLES MARKET 2017-2025 ($MILLION)

FIGURE # 9  GLOBAL SOFTWARE & SERVICES MARKET 2017-2025 ($MILLION)

FIGURE # 10            GLOBAL CLINICAL MARKET 2017-2025 ($MILLION)

FIGURE # 11            TOTAL US MEDICAL AND HEALTH R&D SPENDING ($MILLION)

FIGURE # 12            GLOBAL RESEARCH MARKET 2017-2025 ($MILLION)

FIGURE # 13            GLOBAL FORENSIC MARKET 2017-2025 ($MILLION)

FIGURE # 14            ACADEMIC AND RESEARCH INSTITUTION FUND IN USA ($MILLION)

FIGURE # 15            GLOBAL RESEARCH LABORATORY AND ACADEMIC INSTITUTES MARKET 2017-2025 ($MILLION)

FIGURE # 16            GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES MARKET 2017-2025 ($MILLION)

FIGURE # 17            GLOBAL CLINICAL RESEARCH ORGANIZATION MARKET 2017-2025 ($MILLION)

FIGURE # 18            GLOBAL FORENSIC LABORATORIES MARKET 2017-2025 ($MILLION)

FIGURE # 19            GROWTH OF THE COUNTRIES CAGR FOR THE FORECASTED PERIOD 2017-2025

FIGURE # 20            APAC REVENUE GROWTH 2017-2025 ($MILLION)

FIGURE # 21            POPULATION OF NORTH AMERICA 2016 (MILLION)

FIGURE # 22            PERCENT OF POPULATION WITH AGE

FIGURE # 23            UNITED STATES (U.S.) DIGITAL PCR MARKET 2017-2025 ($MILLION)

FIGURE # 24            NUMBER OF PERSONS 65+, 2014 TO 2023 (NO. IN MILLIONS)

FIGURE # 25            CANADA DIGITAL PCR MARKET 2017-2025 ($MILLION)

FIGURE # 26            ESTIMATES OF POPULATION, BY AGE GROUP AND SEX

FIGURE # 27            EUROPE DIGITAL PCR MARKET

FIGURE # 28            UNITED KINGDOM (UK) DIGITAL PCR MARKET 2017-2025 ($MILLION)

FIGURE # 29            GLOBAL MEN AND WOMEN CANCER MORTALITY 2016

FIGURE # 30            GERMANY DIGITAL PCR MARKET 2017-2025 ($MILLION)

FIGURE # 31            SPAIN DIGITAL PCR MARKET 2017-2025 ($MILLION)

FIGURE # 32            REST OF EUROPE DIGITAL PCR MARKET 2017-2025 ($MILLION)

FIGURE # 33            INDIA DIGITAL PCR MARKET 2017-2025 ($MILLION)

FIGURE # 34            CANCER INCIDENCE RATE IN ASIAN COUNTRIES BY GENDER 2016

FIGURE # 35            CHINA DIGITAL PCR MARKET 2017-2025 ($MILLION)

FIGURE # 36            JAPAN LIFE EXPECTANCY RATE 2013-2015 (IN YEARS)

FIGURE # 37            JAPAN DIGITAL PCR MARKET 2017-2025 ($MILLION)

FIGURE # 38            ROAPAC DIGITAL PCR MARKET 2017-2025 ($MILLION)

FIGURE # 41            LATIN AMERICA DIGITAL PCR MARKET 2017-2025 ($MILLION)

FIGURE # 42            MIDDLE EAST AND AFRICA DIGITAL PCR MARKET 2017-2025 ($MILLION)

FIGURE # 45            MARKET SHARE ANALYSIS OF KEY PLAYERS IN DIGITAL PCR MARKET 2016
FIGURE 1 GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)
FIGURE 2 GLOBAL CONTRAST REAGENTS MARKET 2017-2025 ($ MILLION)
FIGURE 3 GLOBAL OPTICALREAGENTS MARKET 2017-2025 ($ MILLION)
FIGURE 4 GLOBAL NUCLEAR REAGENTS MARKET 2017-2025 ($ MILLION)
FIGURE 5 GLOBAL SMALL CHEMICALS MARKET 2017-2025 ($ MILLION)
FIGURE 6 GLOBAL PROBES MARKET 2017-2025 ($ MILLION)
FIGURE 7 GLOBAL RADIOTRACERS MARKET 2017-2025 ($ MILLION)
FIGURE 8 GLOBAL CHELATING MOLECULES MARKET 2017-2025 ($ MILLION)
FIGURE 9 GLOBAL MICRO BUBBLES MARKET 2017-2025 ($ MILLION)
FIGURE 10 GLOBAL FLUORESCENT PROTEINS MARKET 2017-2025 ($ MILLION)
FIGURE 11 GLOBAL NANOPARTICLES MARKET 2017-2025 ($ MILLION)
FIGURE 12 GLOBAL DIAGNOSTICS MARKET 2017-2025 ($ MILLION)
FIGURE 13 GLOBAL RESEARCH AND DEVELOPMENT MARKET 2017-2025 ($ MILLION)
FIGURE 14 GLOBAL CONTRAST IMAGING MARKET 2017-2025 ($ MILLION)
FIGURE 15 GLOBAL OPTICAL IMAGING MARKET 2017-2025 ($ MILLION)
FIGURE 16 GLOBAL PROTEOMICS MARKET 2017-2025 ($ MILLION)
FIGURE 17 GLOBAL GENOMICS MARKET 2017-2025 ($ MILLION)
FIGURE 18 GLOBAL CELL BIOLOGY MARKET 2017-2025 ($ MILLION)
FIGURE 19 GLOBAL INVIVO MARKET 2017-2025 ($ MILLION)
FIGURE 20 GLOBAL RADIOACTIVE IMAGING MARKET 2017-2025 ($ MILLION)
FIGURE 21 GLOBAL IN-VIVO MARKET 2017-2025 ($ MILLION)
FIGURE 22 GLOBAL IN-VITRO MARKET 2017-2025 ($ MILLION)
FIGURE 23 GLOBAL OPTICAL MARKET 2017-2025 ($ MILLION)
FIGURE 24 GLOBAL X-RAY/CT MARKET 2017-2025 ($ MILLION)
FIGURE 25 GLOBAL NUCLEAR MARKET 2017-2025 ($ MILLION)
FIGURE 26 GLOBAL SPECT MARKET 2017-2025 ($ MILLION)
FIGURE 27 GLOBAL PET MARKET 2017-2025 ($ MILLION)
FIGURE 28 GLOBAL MRI MARKET 2017-2025 ($ MILLION)
FIGURE 29 GLOBAL ULTRASOUND MARKET 2017-2025 ($ MILLION)
FIGURE 30 PORTER’S FIVE FORCE MODEL OF BIOLOGICAL IMAGING REGENTS MARKET
FIGURE 31 BIOTECHNOLOGY FIRMS ACROSS COUNTRIES 2016
FIGURE 32 WORLDWIDE TOTAL PHARMACEUTICAL R&D EXPENDITURE 2015-2020 ($ BILLION)
FIGURE 33 KEY BUYING FACTORS OF BIOLOGICAL IMAGING REAGENTS 2017-2025
FIGURE 34 NORTH AMERICA BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)
FIGURE 35 UNITED STATES BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)
FIGURE 36 CANADA BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)
FIGURE 37 UNITED KINGDOM BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)
FIGURE 38 FRANCE BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)
FIGURE 39 MORTALITY RATE DUE TO CHRONIC DISEASES IN FRANCE
FIGURE 40 GERMANY BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)
FIGURE 41 BIOTECHNOLOGY APPLICATIONS IN GERMANY
FIGURE 42 REST OF EUROPE BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)
FIGURE 43 CHINA BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)
FIGURE 44 INDIA BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)
FIGURE 45 JAPAN BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)
FIGURE 46 APPLICATION OF JAPANESE BIOTECHNOLOGY
FIGURE 47 REST OF ASIA PACIFIC BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)
FIGURE 48 LATIN AMERICA BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)
FIGURE 49 MIDDLE EAST AND NORTH AFRICA BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)
FIGURE 50 REST OF AFRICA BIOLOGICAL IMAGING REAGENTS MARKET 2017-2025 ($ MILLION)

  1. MARKET SEGMENTATION
    • BY CLASS
      • CONTRAST REAGENTS
      • OPTICAL REAGENTS
      • NUCLEAR REAGENTS
    • BY TECHNOLOGY
      • SMALL CHEMICALS
      • PROBES
      • RADIOTRACERS
      • CHELATING MOLECULES
      • MICRO BUBBLES
      • FLUORESCENT PROTEINS
      • NANOPARTICLES
    • BY END USER
      • DIAGNOSTICS
      • RESEARCH AND DEVELOPMENT
    • BY APPLICATION
      • CONTRAST IMAGING
      • OPTICAL IMAGING
        • IN-VITRO
          • PROTEOMICS
          • GENOMICS
          • CELL BIOLOGY
        • IN-VIVO
      • RADIOACTIVE IMAGING
    • BY END-USE
      • IN-VIVO
      • IN-VITRO
    • BY MODALITY
      • OPTICAL
      • X-RAY/CT
      • NUCLEAR
        • SPECT
        • PET
      • MRI
      • ULTRASOUND
  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • UNITED STATES
      • CANADA
    • EUROPE
      • UNITED KINGDOM
      • FRANCE
      • GERMANY
      • REST OF EUROPE
    • ASIA PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • REST OF ASIA PACIFIC
    • REST OF THE WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND NORTH AFRICA
      • REST OF AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    Choose License Type